Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (351-360 of 366) with videos related to

Pageof 37
Sort By:
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Blood|April 1, 1981
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remissionA Friedman, P Schauer, R Mertelsmann, et al.
Bone Marrow Transplantation|September 1, 2009
Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumorL Houet, I Möller, M Engelhardt, et al.
Haematology and Blood Transfusion|January 1, 1983
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromesK Welte, S Venuta, C Y Wang, et al.
Human Gene Therapy|May 15, 1998
Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing mediumH Glimm, K Flügge, D Möbest, et al.
British Journal of Haematology|October 1, 1991
Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFN alpha) in metastatic melanomaW H Kruit, S H Goey, J R Monson, et al.
Medicine|November 1, 1980
The acute monocytic leukemias: multidisciplinary studies in 45 patientsD J Straus, R Mertelsmann, B Koziner, et al.
International Journal of Cancer|January 27, 1997
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancerH Veelken, A Mackensen, M Lahn, et al.
Cancer|November 15, 1981
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocolR Mertelsmann, R L Drapkin, T S Gee, et al.
Cell|May 30, 1997
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasiaS Mundlos, F Otto, C Mundlos, et al.
Pageof 37

Showing results (351-360 of 366) with videos related to

Sort By:
Pageof 37
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Blood|April 1, 1981
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remissionA Friedman, P Schauer, R Mertelsmann, et al.
Bone Marrow Transplantation|September 1, 2009
Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumorL Houet, I Möller, M Engelhardt, et al.
Haematology and Blood Transfusion|January 1, 1983
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromesK Welte, S Venuta, C Y Wang, et al.
Human Gene Therapy|May 15, 1998
Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing mediumH Glimm, K Flügge, D Möbest, et al.
British Journal of Haematology|October 1, 1991
Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFN alpha) in metastatic melanomaW H Kruit, S H Goey, J R Monson, et al.
Medicine|November 1, 1980
The acute monocytic leukemias: multidisciplinary studies in 45 patientsD J Straus, R Mertelsmann, B Koziner, et al.
International Journal of Cancer|January 27, 1997
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancerH Veelken, A Mackensen, M Lahn, et al.
Cancer|November 15, 1981
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocolR Mertelsmann, R L Drapkin, T S Gee, et al.
Cell|May 30, 1997
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasiaS Mundlos, F Otto, C Mundlos, et al.
Pageof 37